CDKN1A and neoplasm: Since genotoxic agent treatment can induce p21 upregulation but has no influence on the levels CMTM6, we speculate that the expression levels of CMTM6 but not p21 in the initial tumors might be a potential biomarker to reflect the sensitivity of tumor to TACE.